US equities
|
MU
$989.04
▲+0.00%
SNDK
$1,487.33
▲+0.00%
META
$742.96
▲+0.00%
NVDA
$226.32
▲+0.00%
SKHY
$162.23
▲+0.00%
GS
$893.95
▲+0.00%
JPM
$334.30
▲+0.00%
UNH
$378.52
▲+0.00%
MU
$989.04
▲+0.00%
SNDK
$1,487.33
▲+0.00%
META
$742.96
▲+0.00%
NVDA
$226.32
▲+0.00%
SKHY
$162.23
▲+0.00%
GS
$893.95
▲+0.00%
JPM
$334.30
▲+0.00%
UNH
$378.52
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about JP:4901
Recent news which mentions JP:4901
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
Tickers
APLIF
AVIR
MRK
PFE
Tags
JP:4901
RDY
MRK
From
MarketWatch